Nektar Therapeutics Sues Eli Lilly For Breach Of Contract, Negligent Misrepresentation; Nektar Accuses Lilly Of Trying To Undermine Rezpeg, Which Nektar Developed To Treat Various Autoimmune Diseases
Portfolio Pulse from Happy Mohamed
Nektar Therapeutics has filed a lawsuit against Eli Lilly for breach of contract and negligent misrepresentation. Nektar accuses Lilly of attempting to undermine Rezpeg, a drug developed by Nektar to treat various autoimmune diseases.
August 07, 2023 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly is being sued by Nektar Therapeutics for alleged breach of contract and negligent misrepresentation. This could potentially impact Eli Lilly's business and stock price.
The lawsuit filed by Nektar against Eli Lilly could potentially lead to financial losses and reputational damage for Eli Lilly. This could negatively impact Eli Lilly's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Nektar Therapeutics has sued Eli Lilly, alleging breach of contract and negligent misrepresentation. This could potentially impact Nektar's business and stock price.
The lawsuit filed by Nektar against Eli Lilly could potentially lead to financial losses and reputational damage for Nektar. This could negatively impact Nektar's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100